Research Topics
| James E FramptonSummaryAffiliation: Adis International Limited Country: New Zealand Publications
| Collaborators
|
Detail Information
Publications
Tramadol/paracetamolKaren McClellan
Adis International Limited, Mairangi Bay, Auckland, New Zealand
Drugs 63:1079-86; discussion 1087-8. 2003..5/325 mg provided similar efficacy to that of codeine/paracetamol 30/300 mg in patients with chronic back pain in a 4-week, randomised, double-blind trial (a maximum of 10 tablets or capsules per day of the active drug)...
Latanoprost : an update of its use in glaucoma and ocular hypertensionCaroline M Perry
Adis International Limited, Mairangi Bay, Auckland, New Zealand
Drugs Aging 20:597-630. 2003..Although preliminary findings are promising, wider clinical experience is required to define the place of latanoprost in the treatment of angle-closure glaucoma...
Retigabine: in partial seizuresGreg L Plosker
Adis International Limited, Auckland, New Zealand
CNS Drugs 20:601-8; discussion 609-10. 2006..Across all three retigabine groups in the large phase II trial, somnolence (20.3%), dizziness (14.6%), confusion (12.3%) and speech disorder (11.3%) were the most frequent CNS-related adverse events...
Etravirine: a review of its use in the management of treatment-experienced patients with HIV-1 infectionJamie D Croxtall
Adis, Auckland, New Zealand
Drugs 72:847-69. 2012....
Acetylsalicylic acid/esomeprazole fixed-dose combinationCeleste B Burness
Adis, Auckland, New Zealand
Drugs Aging 29:233-42. 2012..Low-dose ASA plus esomeprazole treatment was generally well tolerated, with a similar adverse event profile to that seen with low-dose ASA plus placebo...
Tapentadol extended release: in adults with chronic painSheridan M Hoy
Adis, Auckland, New Zealand
Drugs 72:375-93. 2012..Oral tapentadol ER therapy for up to 24 months was generally well tolerated, with the nature of treatment-emergent adverse events generally similar across the clinical studies...
Argatroban: a review of its use in the management of heparin-induced thrombocytopeniaSohita Dhillon
Wolters Kluwer Health Adis, Auckland, New Zealand
Am J Cardiovasc Drugs 9:261-82. 2009..However, a small uncontrolled, preliminary study suggests that it may be useful in seriously ill pediatric patients requiring nonheparin anticoagulation...
Brinzolamide/timolol: in open-angle glaucoma and ocular hypertensionJamie D Croxtall
Wolters Kluwer Health, Adis, Auckland, New Zealand
Drugs Aging 26:437-46. 2009..Moreover, a significantly greater number of patients expressed a preference for brinzolamide/timolol over dorzolamide/timolol. The main ocular adverse event was blurred vision, and was not considered to be a safety issue...
Losartan/Hydrochlorothiazide: a review of its use in the treatment of hypertension and for stroke risk reduction in patients with hypertension and left ventricular hypertrophyGillian M Keating
Wolters Kluwer Health, Adis, Auckland, New Zealand
Drugs 69:1239-65. 2009..Losartan/HCTZ is a well tolerated combination therapy. Thus, losartan/HCTZ remains an important option in the treatment of hypertension, as well as being indicated to reduce stroke risk in patients with hypertension and LVH...
Intranasal sumatriptan: in adolescents with migraineMonique P Curran
Adis International Limited, Auckland, New Zealand
CNS Drugs 19:335-43; discussion 345-6. 2005..Taste disturbance occurred more often with intranasal sumatriptan than with placebo [Chart: see text]...
Efalizumab: a review of its use in the management of chronic moderate-to-severe plaque psoriasisJames E Frampton
Wolters Kluwer Health Adis, 41 Centorian Drive, Private Bag 65901, Mairangi Bay, North Shore 0754, Auckland, New Zealand
Am J Clin Dermatol 10:51-72. 2009....
Human papillomavirus types 16 and 18 vaccine (recombinant, AS04 adjuvanted, adsorbed) [Cervarix]: profile reportSusan J Keam
Wolters Kluwer Health Adis, Auckland, New Zealand
BioDrugs 22:205-8. 2008
Alitretinoin: in severe chronic hand eczemaKarly P Garnock-Jones
Wolters Kluwer Health Adis, 41 Centorian Drive, Mairangi Bay, North Shore 0754, Auckland, New Zealand
Drugs 69:1625-34. 2009..The most common treatment-emergent adverse events and abnormal laboratory test results were consistent with those previously observed with other oral retinoids and RXR agonists...
Nesiritide: a review of its use in acute decompensated heart failureGillian M Keating
Adis International Limited, Mairangi Bay, Auckland, New Zealand
Drugs 63:47-70. 2003..Thus, nesiritide is a suitable first-line option for the treatment of patients with acutely decompensated CHF and is a welcome addition in an area where intravenous agents are few...
Pregabalin: in the treatment of postherpetic neuralgiaKate McKeage
Adis, a Wolters Kluwer Business, Auckland, New Zealand
Drugs Aging 26:883-92. 2009..Pregabalin was generally well tolerated when titrated over 1 week to fixed dosages (maximum 600 mg/day) in clinical trials in mostly elderly PHN patients. Adverse events were usually mild to moderate in severity...
Everolimus: in advanced renal cell carcinomaKarly P Garnock-Jones
Adis, Auckland, New Zealand
Drugs 69:2115-24. 2009..The tolerability profile of everolimus was largely manageable in the phase III trial, with most treatment-related adverse events being of grade 1 or 2 severity...
Airmax: a multi-dose dry powder inhalerGillian M Keating
Adis International Limited, Auckland, New Zealand
Drugs 62:1887-95; discussion 1896-7. 2002..Both adults and children preferred Airmax to Turbuhaler, and more found Airmax easier to use. In one study, the majority of children found learning how to use Airmax trade mark easier than learning how to use Turbuhaler...
Pneumococcal conjugate vaccine (Prevnar; PNCRM7): a review of its use in the prevention of Streptococcus pneumoniae infectionMalcolm J M Darkes
Adis International Inc, Langhorne, Pennsylvania 19047, USA
Paediatr Drugs 4:609-30. 2002..pneumoniae infections. In developed countries, the vaccine will be of particular benefit in preventing disabling infections but its impact in developing countries will be more pronounced with the potential to greatly reduce mortality...
Trabectedin: a review of its use in soft tissue sarcoma and ovarian cancerNatalie J Carter
Adis, a Wolters Kluwer Business, Auckland, New Zealand
Drugs 70:355-76. 2010....
Perindopril: in congestive heart failureDene Simpson
Adis International Limited, Auckland, New Zealand
Drugs 62:1367-77; discussion 1378-9. 2002....
Histrelin: in advanced prostate cancerEmma D Deeks
Adis, a Wolters Kluwer Business, Auckland, New Zealand
Drugs 70:623-30. 2010..No patients prematurely discontinued treatment because of adverse events, most of which were the consequence of hormone suppression...
Mosapride in gastrointestinal disordersMonique P Curran
Wolters Kluwer Health, Adis, Auckland, New Zealand
Drugs 68:981-91. 2008..Mosapride was well tolerated, with diarrhoea/loose stools, dry mouth, malaise and headache being reported in <5% of patients...
Bemiparin: a review of its use in the prevention of venous thromboembolism and treatment of deep vein thrombosisTherese M Chapman
Adis International Limited, Auckland, New Zealand
Drugs 63:2357-77. 2003..In the meantime, available data suggest that bemiparin is an effective and useful addition to the available range of LMWHs for the prevention of VTE and treatment of DVT...
Zoledronic acid : a review of its use in the management of bone metastases of malignancySohita Dhillon
Wolters Kluwer Health Adis, Auckland, New Zealand
Drugs 68:507-34. 2008..Nevertheless, available clinical data indicate that zoledronic acid is an effective treatment option for the management of bone metastases of malignancy...
Zonisamide: a review of its use in the management of partial seizures in epilepsyJames E Frampton
Adis International Limited, Auckland, New Zealand
CNS Drugs 19:347-67. 2005..In the meantime, adjunctive therapy or monotherapy with zonisamide is a convenient, useful option for the management of partial seizures, including those refractory to other AEDs...
Lansoprazole: in the treatment of gastro-oesophageal reflux disease in children and adolescentsKatherine F Croom
Adis International Limited, Auckland, New Zealand
Drugs 65:2129-35; discussion 2136-7. 2005..Lansoprazole was generally well tolerated in children and adolescents, with the most common treatment-related adverse events being gastrointestinal events and headache...
Solifenacin in overactive bladder syndromeDene Simpson
Adis International Limited, Auckland, New Zealand
Drugs Aging 22:1061-9. 2005..Solifenacin was generally well tolerated; the most frequently reported adverse events were dry mouth, constipation and blurred vision...
Darifenacin: in the treatment of overactive bladderKatherine F Croom
Adis International Limited, Auckland, New Zealand
Drugs Aging 21:885-92; discussion 893-4. 2004..The most common adverse events were dry mouth and constipation. CNS tolerability appeared to be similar to that of placebo. Darifenacin had no adverse effect on cognitive function in healthy elderly volunteers...
AnidulafunginDavid Murdoch
Adis International Limited, Auckland, New Zealand
Drugs 64:2249-58; discussion 2259-60. 2004..In the largest clinical trial to date, the most common treatment-related adverse events were phlebitis/thrombophlebitis, headache, nausea, vomiting and pyrexia...
Insulin aspart: a review of its use in the management of type 1 or 2 diabetes mellitusNeil A Reynolds
Adis International Limited, Auckland, New Zealand
Drugs 64:1957-74. 2004..Insulin aspart is an effective and well tolerated alternative to regular human insulin and insulin lispro for the maintenance of glycaemic control in patients with type 1 or 2 diabetes...
Modified-release nifedipine: a review of the use of modified-release formulations in the treatment of hypertension and angina pectorisKatherine F Croom
Adis International Limited, Auckland, New Zealand
Drugs 66:497-528. 2006....
GadofosvesetSheridan Henness
Adis International Limited, 41 Centorian Drive, Mairangi Bay, Auckland 1311, New Zealand
Drugs 66:851-7. 2006..Gadofosveset was generally well tolerated in clinical trials, with most adverse events being mild or moderate in severity...
Clopidogrel: a pharmacoeconomic review of its use in patients with non-ST elevation acute coronary syndromesKatherine A Lyseng-Williamson
Adis International Limited, Mairangi Bay, Auckland, New Zealand
Pharmacoeconomics 24:709-26. 2006..Available pharmacoeconomic data from several countries, despite some inherent limitations, support the use of clopidogrel plus aspirin for up to 1 year as a cost-effective treatment relative to aspirin alone in this patient population...
Intravenous ibandronate: in the treatment of osteoporosisKatherine F Croom
Adis International Limited, Mairangi Bay, Auckland, New Zealand
Drugs 66:1593-601; discussion 1602-3. 2006..IV ibandronate was generally well tolerated in clinical trials. Treatment-related adverse events included musculoskeletal events and transient influenza-like symptoms, the latter mainly associated with the first dose...
Orlistat: a review of its use in the management of obesitySheridan Henness
Adis International Limited, Mairangi Bay, Auckland, New Zealand
Drugs 66:1625-56. 2006..Thus, orlistat is an option for the treatment of obese patients with or without type 2 diabetes and also has a role in the management of obese patients with the metabolic syndrome, associated comorbidities or concomitant disorders...
Ximelagatran/Melagatran: a review of its use in the prevention of venous thromboembolism in orthopaedic surgeryHannah C Evans
Adis International Limited, 41 Centorian Drive, PB 65901, Mairangi Bay, Auckland 1311, New Zealand
Drugs 64:649-78. 2004..Thus, on the basis of available evidence, ximelagatran/melagatran appears poised to play an important role in the prophylaxis of VTE in patients undergoing orthopaedic surgery...
Epoetin Beta: a review of its clinical use in the treatment of anaemia in patients with cancerSusan M Cheer
Adis International Limited, Mairangi Bay, Auckland, New Zealand
Drugs 64:323-46. 2004..Epoetin beta is an important option in the prevention of chemotherapy-induced anaemia, and a valid and valuable alternative to blood transfusion therapy for the treatment of cancer-related or chemotherapy-induced anaemia...
Cetuximab: in the treatment of metastatic colorectal cancerNeil A Reynolds
Adis International Limited, Mairangi Bay, Auckland 1311, New Zealand
Drugs 64:109-18; discussion 119-121. 2004..In patients receiving cetuximab plus irinotecan, these were diarrhoea, asthenia, leucopenia and neutropenia...
Bivalirudin: in patients with ST-segment elevation myocardial infarctionMonique P Curran
Adis, Wolters Kluwer Business, Auckland, New Zealand
Drugs 70:909-18. 2010....
Mifamurtide: a review of its use in the treatment of osteosarcomaJames E Frampton
Adis, a Wolters Kluwer Business, Mairangi Bay, North Shore, Auckland, New Zealand
Paediatr Drugs 12:141-53. 2010..Based on the available data, mifamurtide can be considered for inclusion in treatment protocols for localized osteosarcoma...
Eltrombopag: a review of its use in treatment-refractory chronic primary immune thrombocytopeniaKarly P Garnock-Jones
Adis, a Wolters Kluwer Business, Auckland, New Zealand
Drugs 71:1333-53. 2011..Eltrombopag is an effective treatment option for adult patients with chronic ITP and an increased risk of bleeding who are refractory to previous treatments, including splenectomy, as demonstrated in well designed clinical trials...
BexaroteneM N Lowe
Adis International Limited, Auckland, New Zealand
Am J Clin Dermatol 1:245-50; discussion 251-2. 2000..Reversible acute pancreatitis has occurred during oral bexarotene therapy. Adverse events associated with the topical formulation are limited to rash, pruritus, and pain...
Denosumab: in cancer treatment-induced bone lossVictoria J Muir
Adis, a Wolters Kluwer Business, Auckland, New Zealand
BioDrugs 24:379-86. 2010..Denosumab treatment was generally well tolerated for up to 24 months in breast cancer patients and for up to 36 months in prostate cancer patients...
Tdap5 vaccine (Covaxis): a review of its use as a single-booster immunization for the prevention of tetanus, diphtheria, and pertussis in children (aged 4 years), adolescents, and adultsLesley J Scott
Adis, a Wolters Kluwer Business, Auckland, New Zealand
BioDrugs 24:387-406. 2010....
Fexofenadine: a review of its use in the management of seasonal allergic rhinitis and chronic idiopathic urticariaK Simpson
Adis International Limited, Mairangi Bay, Auckland, New Zealand
Drugs 59:301-21. 2000..In those with excessive nasal congestion the combination of fexofenadine plus pseudoephedrine may be useful. In clinical trials fexofenadine is not associated with adverse cardiac or cognitive/psychomotor effects...
Docetaxel: an update of its use in advanced breast cancerD P Figgitt
Adis International Limited, Mairangi Bay, Auckland, New Zealand
Drugs 59:621-51. 2000..The role of docetaxel in the adjuvant and neoadjuvant treatment of early breast cancer is being evaluated...
Linezolid: a review of its use in the management of serious gram-positive infectionsC M Perry
Adis International Limited, Auckland, New Zealand
Drugs 61:525-51. 2001..As the level of resistance to vancomycin increases among S. aureus and enterococci, linezolid is poised to play an important role in the management of serious gram-positive infections...
Darbepoetin alfaT Ibbotson
Adis International Limited, Auckland, New Zealand
Drugs 61:2097-104; discussion 2105-6. 2001..There have been no reports of immune responses to darbepoetin alfa in 1534 patients receiving treatment for up to 2 years...
LinezolidD Clemett
Adis International Limited, Mairangi Bay, Auckland, New Zealand
Drugs 59:815-27; discussion 828. 2000..Linezolid is generally well tolerated and gastrointestinal disturbances are the most commonly occurring adverse events. No clinical evidence of adverse reactions as a result of monoamine oxidase inhibition has been reported...
Ropinirole: a review of its use in the management of Parkinson's diseaseA J Matheson
Adis International Limited, Auckland, New Zealand
Drugs 60:115-37. 2000..In addition, ropinirole is also efficacious in the management of more advanced Parkinson's disease in patients who are experiencing motor complications after long term levodopa use...
Plerixafor: a review of its use in stem-cell mobilization in patients with lymphoma or multiple myelomaGillian M Keating
Adis, a Wolters Kluwer Business, Auckland, New Zealand
Drugs 71:1623-47. 2011..In conclusion, plerixafor is a valuable stem-cell mobilizer for use in combination with G-CSF in patients with lymphoma or MM, particularly in patients who are poor mobilizers or predicted poor mobilizers...
Budesonide inhalation suspension: a review of its use in infants, children and adults with inflammatory respiratory disordersK M Hvizdos
Adis International Limited, Auckland, New Zealand
Drugs 60:1141-78. 2000..The preparation is suitable for use in infants, children and adults with persistent asthma and in infants and children with croup...
Topical aminolevulinic acid HCl photodynamic therapyD Ormrod
Adis International Limited, Auckland, New Zealand
Am J Clin Dermatol 1:133-9; discussion 140-1. 2000..Localized erythema and edema were also common. No other significant adverse effects were noted and treatment was generally well tolerated. A well designed dermal applicator ensured perilesional skin was spared collateral damage...
Spinosad: in pediculosis capitisPaul L McCormack
Adis, a Wolters Kluwer Business, Auckland, New Zealand
Am J Clin Dermatol 12:349-53. 2011..Spinosad was generally well tolerated in clinical trials, with no severe or serious adverse events. Cutaneous and ocular irritation were the most common adverse events...
Olanzapine: a review of its use in the treatment of bipolar I disorderN Bhana
Adis International Limited, Auckland, New Zealand
CNS Drugs 15:871-904. 2001..Available data support the choice of olanzapine as an option in the short-term management of mania in patients with bipolar I disorder with manic or mixed episodes, with or without psychotic features...
Topical dorzolamide 2%/timolol 0.5%: a review of its use in the treatment of open-angle glaucomaD Ormrod
Adis International Limited, Auckland, New Zealand
Drugs Aging 17:477-96. 2000..Nonetheless, dorzolamide combined with timolol in a single applicator system will be a useful addition to the treatment options for glaucoma, a leading cause of preventable blindness...
Mirtazapine: a review of its use in major depressionK J Holm
Adis International Limited, Mairangi Bay, Auckland, New Zealand
Drugs 57:607-31. 1999..Mirtazapine also appears to be useful in patients with depression who present with anxiety symptoms and sleep disturbance...
Drotrecogin alfa (activated)Katherine A Lyseng-Williamson
Adis International Limited, Auckland, New Zealand
Drugs 62:617-30; discussion 631-2. 2002..Of the 210 deaths in patients with severe sepsis treated with drotrecogin alfa (activated) 24 microg/kg/h in the efficacy trial, four deaths due to haemorrhage and one due to cerebral oedema were possibly related to the study drug...
Fenoldopam: a review of its pharmacodynamic and pharmacokinetic properties and intravenous clinical potential in the management of hypertensive urgencies and emergenciesR N Brogden
Adis International Limited, Auckland, New Zealand
Drugs 54:634-50. 1997..Fenoldopam may be particularly useful in patients who develop hypertension after coronary artery bypass graft surgery, but further studies are required to confirm its role in hypertensive emergency...
Pramipexole. A review of its use in the management of early and advanced Parkinson's diseaseM Dooley
Adis International Limited, Auckland, New Zealand
Drugs Aging 12:495-514. 1998..The efficacy of pramipexole monotherapy in patients with early disease has also been demonstrated, although the use of dopamine agonists in early Parkinson's disease remains controversial...
Pharmacoeconomic spotlight on varenicline as an aid to smoking cessationGillian M Keating
Adis, a Wolters Kluwer Business, Auckland, New Zealand
CNS Drugs 24:797-800. 2010....
DTPa-HBV-IPV/Hib Vaccine (Infanrix hexa): A Review of its Use as Primary and Booster VaccinationSohita Dhillon
Adis, a Wolters Kluwer Business, Auckland, New Zealand
Drugs 70:1021-58. 2010....
Tizanidine. A review of its pharmacology, clinical efficacy and tolerability in the management of spasticity associated with cerebral and spinal disordersA J Wagstaff
Adis International Limited, Auckland, New Zealand
Drugs 53:435-52. 1997..Tizanidine, therefore, appears to be an attractive therapeutic alternative for patients with spasticity associated with cerebral or spinal damage...
DonepezilH M Bryson
Adis International Limited, Auckland, New Zealand
Drugs Aging 10:234-9; discussion 240-1. 1997..No hepatotoxicity was reported after 12 weeks' treatment...
Trastuzumab: in HER2-positive metastatic gastric cancerJamie D Croxtall
Adis, a Wolters Kluwer Business, Auckland, New Zealand
Drugs 70:2259-67. 2010..In general, combination therapy with trastuzumab and chemotherapy was relatively well tolerated in patients with metastatic gastric cancer with no reports of new or unexpected adverse events...
Intanza 15 microg intradermal seasonal influenza vaccine: in older adults (aged >or=60 years)Sean T Duggan
Adis, a Wolters Kluwer Business, Auckland, New Zealand
Drugs Aging 27:597-605. 2010....
Topical pimecrolimus: a review of its clinical potential in the management of atopic dermatitisKeri Wellington
Adis International Limited, Auckland, New Zealand
Drugs 62:817-40. 2002..Pimecrolimus 1.0% cream provides a promising and well tolerated treatment option in the management of infants, children and adults with mild to moderate atopic dermatitis...
Telmisartan: a review of its use in the management of hypertensionAnna J Battershill
Adis International Limited, Auckland, New Zealand
Drugs 66:51-83. 2006....
EverolimusTherese M Chapman
Adis International Limited, Mairangi Bay, Auckland, New Zealand
Drugs 64:861-72; discussion 873-4. 2004..Everolimus has been associated with thrombocytopenia, leucopenia and elevated serum lipids and creatinine...
Adalimumab: a review of its use in rheumatoid arthritisLynne M Bang
Adis International Inc, 770 Township Line Road, Suite 300, Yardley, PA 19067, USA
BioDrugs 18:121-39. 2004..The drug also retards the progression of structural joint damage, improves HR-QOL, and is generally well tolerated. Thus, adalimumab is a valuable new option for the treatment of DMARD-refractory adult rheumatoid arthritis...
Voriconazole: in the treatment of invasive aspergillosisRichard B R Muijsers
Adis International Limited, Mairangi Bay, Auckland, New Zealand
Drugs 62:2655-64; discussion 2665-6. 2002..02 both comparisons) fewer treatment-related adverse events or serious adverse events. The incidence of visual disturbances was significantly (p < 0.001) higher with voriconazole than amphotericin B treatment...
Pioglitazone: a review of its use in type 2 diabetes mellitusJohn Waugh
Adis International Limited, Auckland, New Zealand
Drugs 66:85-109. 2006..Pioglitazone was also effective in reducing some measures of cardiovascular risk and arteriosclerosis. Pioglitazone thus offers an effective treatment option for the management of patients with type 2 diabetes...
Varenicline: a pharmacoeconomic review of its use as an aid to smoking cessationGillian M Keating
Adis, a Wolters Kluwer Business, Auckland, New Zealand
Pharmacoeconomics 28:231-54. 2010....
Remifentanil : a review of its analgesic and sedative use in the intensive care unitAnna J Battershill
Adis International Limited, Auckland, New Zealand
Drugs 66:365-85. 2006..Thus, remifentanil is a welcome addition to the currently available pharmacological agents employed in the management of mechanically ventilated ICU patients...
Lansoprazole: in the management of gastroesophageal reflux disease in childrenLesley J Scott
Adis International Inc, Langhorne, Pennsylvania 10947, USA
Paediatr Drugs 5:57-61; discussion 62. 2003..The drug is generally well tolerated in children with GERD. In the largest study, the most common treatment-related adverse events occurring during therapy were constipation and headache...
Fixed combination trandolapril/verapamil sustained-release: a review of its use in essential hypertensionRichard B R Muijsers
Adis International Limited, Auckland, New Zealand
Drugs 62:2539-67. 2002..Data from large clinical trials currently being conducted will assist in fully defining the role of trandolapril/verapamil SR as a cardio- and renoprotective agent...
Glucosamine: a review of its use in the management of osteoarthritisAnna J Matheson
Adis International Limited, Auckland, New Zealand
Drugs Aging 20:1041-60. 2003..In addition, glucosamine has shown promising results in modifying the progression of arthritis over a 3-year period. Glucosamine may therefore prove to be a useful treatment option for osteoarthritis...
Clarithromycin extended-release tablet: a review of its use in the management of respiratory tract infectionsMalcolm J M Darkes
Adis International Inc, Langhorne, Pennsylvania, USA
Am J Respir Med 2:175-201. 2003..The reformulation modulates clarithromycin absorption kinetics thereby improving tolerability. Therefore, clarithromycin extended-release provides a useful option for the treatment of specific respiratory tract infections...
MicafunginBlair Jarvis
Adis International Limited, 41 Centorial Drive, Mairangi Bay, Auckland 1311, New Zealand
Drugs 64:969-82; discussion 983-4. 2004..5-900 mg/day; no histamine-like reactions occurred. Micafungin was as well tolerated as fluconazole, with numerically fewer micafungin recipients discontinuing treatment (4.2% vs 7.2%)...
Reteplase: a review of its use in the management of thrombotic occlusive disordersDene Simpson
Adis International Inc, Yardley, Pennsylvania 19067, USA
Am J Cardiovasc Drugs 6:265-85. 2006....
Goserelin: a review of its use in the treatment of early breast cancer in premenopausal and perimenopausal womenSusan M Cheer
Adis International Limited, Auckland, New Zealand
Drugs 65:2639-55. 2005....
Triflusal: a review of its use in cerebral infarction and myocardial infarction, and as thromboprophylaxis in atrial fibrillationDavid Murdoch
Adis International Limited, Auckland, New Zealand
Drugs 66:671-92. 2006....
Insulin lispro: a pharmacoeconomic review of its use in diabetes mellitusChristopher J Dunn
Adis International Limited, Auckland, New Zealand
Pharmacoeconomics 20:989-1025. 2002..Further research into the pharmacoeconomic implications of insulin lispro use in the long term is needed, particularly with respect to effects on indirect costs and those associated with complications of diabetes mellitus...
Amisulpride: a review of its use in the management of schizophreniaKate McKeage
Adis International Limited, Auckland, New Zealand
CNS Drugs 18:933-56. 2004..Thus, amisulpride is an effective and well tolerated option for the first-line treatment of patients with acute schizophrenia as well as for those requiring long-term maintenance therapy...
Mycophenolate mofetil: a pharmacoeconomic review of its use in solid organ transplantationMelissa Young
Adis International Ltd, Auckland, New Zealand
Pharmacoeconomics 20:675-713. 2002..Additional pharmacoeconomic analyses of mycophenolate mofetil are also needed in other types of solid organ transplantation...
Golimumab: in the treatment of rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitisVicki Oldfield
Wolters Kluwer Health Adis, North Shore, Auckland, New Zealand
BioDrugs 23:125-35. 2009..The tolerability profile of golimumab was generally consistent with that of other anti-TNF agents...
Ziprasidone: a review of its use in schizophrenia and schizoaffective disorderNishan S Gunasekara
Adis International Limited, Auckland, New Zealand
Drugs 62:1217-51. 2002..In addition, intramuscular ziprasidone shows efficacy and good tolerability in the treatment of acute agitation associated with psychotic disorders...
Inhaled salmeterol/fluticasone propionate combination in chronic obstructive pulmonary diseaseKatherine A Lyseng-Williamson
Adis International Inc, Langhorne, Pennsylvania 19047, USA
Am J Respir Med 1:273-82; discussion 283-4. 2002..Candidiasis, hoarseness/dysphonia, throat irritation and headache occurred more frequently with salmeterol/fluticasone propionate than with placebo in patients with COPD...
AtomoxetineDene Simpson
Adis International Inc, Yardley, Pennsylvania 19067, USA
Paediatr Drugs 5:407-15; discussion 416-7. 2003..The most common treatment-related adverse event was decreased appetite. Atomoxetine shows no abuse potential and is not a controlled substance in the US...
Tipranavir: a review of its use in the management of HIV infectionJennifer S Orman
Wolters Kluwer Health Adis, Auckland, New Zealand
Drugs 68:1435-63. 2008..Thus, tipranavir, administered with ritonavir, is an effective treatment option for use in the combination therapy of adults with HIV-1 infection who have been previously treated with other antiretroviral drugs...
Spotlight on gefitinib in non-small-cell lung cancerJames E Frampton
Adis International Inc, Langhorne, Pennsylvania 19047, USA
Am J Pharmacogenomics 5:133-6. 2005..Further studies are needed to fully elucidate the clinical implications of EGFR mutations and to identify patients likely to benefit from EGFR-targeted therapy...
Azelaic acid 15% gel: in the treatment of papulopustular rosaceaJames E Frampton
Adis International Inc, Yardley, Pennsylvania 19067, USA
Am J Clin Dermatol 5:57-64. 2004....
Selegiline transdermal system: in the treatment of major depressive disorderJames E Frampton
Wolters Kluwer Health, Adis, Auckland, New Zealand
Drugs 67:257-65; discussion 266-7. 2007..The incidence of sexual adverse effects and weight gain was low and similar to that with placebo...
DTaP(5)-IPV-Hib vaccine (Pediacel®)James E Frampton
Adis, a Wolters Kluwer Business, Auckland, New Zealand
Paediatr Drugs 13:401-15. 2011..It had an adverse event profile generally similar to that of other combination vaccines based on diphtheria, tetanus and acellular pertussis vaccine, including Infanrix®-IPV+Hib and Infanrix® hexa...
TigecyclineJames E Frampton
Adis International Limited, Auckland, New Zealand
Drugs 65:2623-35; discussion 2636-7. 2005....
Gefitinib: a review of its use in the management of advanced non-small-cell lung cancerJames E Frampton
Adis International Limited, Mairangi Bay, Auckland, New Zealand
Drugs 64:2475-92. 2004..These findings have been supported by observations from a global compassionate-use programme. Ongoing or planned clinical trials are designed to confirm and/or further define the role of the drug in the above and other clinical settings...
Selegiline transdermal system in major depressive disorder: profile reportJames E Frampton
Wolters Kluwer Health/Adis, Auckland, New Zealand
CNS Drugs 21:521-4. 2007
Duloxetine: a review of its use in the treatment of major depressive disorderJames E Frampton
Wolters Kluwer Health, Adis, Auckland, New Zealand
CNS Drugs 21:581-609. 2007..It also appears to be an attractive option for MDD patients presenting with painful physical symptoms...
Aliskiren: a review of its use in the management of hypertensionJames E Frampton
Wolters Kluwer Health Adis, Auckland, New Zealand, an editorial office of Wolters Kluwer Health, Conshohocken, Pennsylvania, USA
Drugs 67:1767-92. 2007..Nonetheless, by offering a new approach to the blockade of the RAS, aliskiren provides a useful addition to the therapeutic options available to treat patients with mild to moderate hypertension...
Pregabalin: in the treatment of painful diabetic peripheral neuropathyJames E Frampton
Adis International Limited, Auckland, New Zealand
Drugs 64:2813-20; discussion 2821. 2004..Pregabalin was well tolerated in DPN patients; mild-to-moderate dizziness, somnolence and peripheral oedema were the most common adverse events...
Hexyl aminolevulinate: in the detection of bladder cancerJames E Frampton
Adis International Limited, Auckland, New Zealand
Drugs 66:571-8; discussion 579-80. 2006..Hexyl aminolevulinate cystoscopy is well tolerated as an adjunct to standard cystoscopy; adverse events were those typically associated with standard cystoscopy/biopsy (e.g. postoperative pain)...
